Assets Under Advice | Fees for 3years | |
35 lacs to 99 lacs | 3% + GST | |
1 Cr to 2.99 Cr | 2.5% + GST | |
3 Cr to 9.99 Cr | 2% + GST | |
10 Cr + | Customised Fees | |
GST @ 18% | ||
|
Please contact us for details | ||
|
TTK Healthcare is currently trading at Rs. 775.15, up by 0.90 points or 0.12% from its previous closing of Rs. 774.25 on the BSE.
The scrip opened at Rs. 835.00 and has touched a high and low of Rs. 835.00 and Rs. 772.30 respectively. So far 2255 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 1110.00 on 12-Sep-2016 and a 52 week low of Rs. 768.00 on 02-May-2017.
Last one week high and low of the scrip stood at Rs. 835.00 and Rs. 768.10 respectively. The current market cap of the company is Rs. 601.98 crore.
The promoters holding in the company stood at 65.43%, while Institutions and Non-Institutions held 10.29% and 24.28% respectively.
Credit rating agency, ICRA has re-affirmed the long-term rating of ‘A+’ outstanding on the Rs 22.50 crore fund-based bank facilities of TTK Healthcare. The rating agency has also reaffirmed the short-term rating of ‘A1+’ outstanding on the Rs 6 crore fund-based facilities (sub limits), the Rs 4.75 crore non-fund based facilities and the Rs 0.25 crore proposed facilities of the company. The outlook on the long-term rating is stable.
TTK Healthcare commenced operations as a pharmaceutical company. Over the years, it diversified its presence across industries and its revenue sources were distributed across many product categories including contraceptives, gripe water, cosmetics, medical devices, home-care products, and food products.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1707.70 |
Dr. Reddys Lab | 1146.30 |
Cipla | 1468.20 |
Lupin | 2000.20 |
Zydus Lifesciences | 876.35 |
View more.. |